Sign In   |   Register
Menu

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

The 2019 Joint European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) Dyslipidaemia Guidelines were released on 31 August during the ESC Congress, Paris, France. These novel ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more clinicians to efficiently and safely reduce CV risk through lipid modification. What were the key changes to those published in 2016? In the video below, the EAS contributors Professor Alberico L. Catapano, Professor Lale Tokgozoglu, and Professor Olov Wiklund describe key changes and what they will mean for practicing clinicians.

Read the guidelines >>
What's new? Read the commentary >>

 

Interactive webinar series on the 2019 Dyslipidaemia Guidelines - available free, on demand

Take the opportunity to understand how the new guidelines apply to your practice, and put your questions to the experts in these free interactive webinars. Experts from EAS take a look at how to use the Guidelines in practice. Each webinar, held on three occasions in December, comprises a 15-min presentation, followed by Q&A with the speaker from the live events. You can expect to learn:

  • What were the key changes in the 2019 Guidelines? What has changed from the earlier version?
  • What lies behind the changes? What is the new evidence?
  • And what do they mean for management of patients’ cardiovascular risk in practice?

Read more and access webinars for free >>

 What's new - video explaning the key messages

From the EAS President

As the year draws to a close, I'd like to take a moment to reflect on the progress we have made in the Society’s activities during 2019. Read more in my "Review of the year" >>

All EAS activities and initiatives are conceived, planned and carried out by dedicated and driven individuals, who devote much time, energy and enthusiasm to the life of the Society. Their engagement enables EAS to run the publication and educational activities that fulfil our mission to advance knowledge in the field of atherosclerosis. I thank the Society's Executive Committee for devoting their time and energy to the Society, and, on their behalf, I take this opportunity to acknowledge and thank most sincerely every contribution, large or small, to the activities of the EAS.

I wish you all health and happiness in the holiday season, and scientific success in 2020 – Hope to see you all at EAS 2020 Geneva!



 
Lale Tokgozoglu MD FACC FESC
President, European Atherosclerosis Society
Professor of Cardiology
Hacettepe University
Ankara-Turkey

Member sign in


Access the Society journals


 

 

Log in to access Atherosclerosis >>

Calendar more

17/12/2019 » 03/02/2020
Nomination for Young Investigator Awards for outstanding publications in 2019

07/02/2020 » 08/02/2020
Clinical Lipidology Course, Istanbul, Turkey

23/02/2020
Advanced Course in Rare Lipid Disease - St Petersburg

EAS Academy
EAS Journal
Become an EAS Member
Guidelines
Membership Software Powered by YourMembership  ::  Legal
This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.